Area:
TMS, tDCS, neuromodulation therapies
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Felipe Fregni is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 2007 — 2008 |
Fregni, Felipe |
M01Activity Code Description:
An award made to an institution solely for the support of a General Clinical Research Center where scientists conduct studies on a wide range of human diseases using the full spectrum of the biomedical sciences. Costs underwritten by these grants include those for renovation, for operational expenses such as staff salaries, equipment, and supplies, and for hospitalization. A General Clinical Research Center is a discrete unit of research beds separated from the general care wards. |
Effect of Tms On Abdominal Pain in Patients With Pancreatic Cancer @ Beth Israel Deaconess Medical Center
Abdominal Pain; Autonomic pain; CRISP; Computer Retrieval of Information on Scientific Projects Database; Dose; Drugs; Funding; Grant; Institution; Investigators; Malignant Pancreatic Neoplasm; Malignant neoplasm of pancreas; Medication; NIH; Narcotics; National Institutes of Health; National Institutes of Health (U.S.); Pain; Painful; Pancreas Cancer; Pancreatic Cancer; Patients; Pharmaceutic Preparations; Pharmaceutical Preparations; QOL; Quality of life; Research; Research Personnel; Research Resources; Researchers; Resources; Source; United States National Institutes of Health; Visceral pain; drug/agent; novel
|
0.921 |
| 2008 |
Fregni, Felipe |
M01Activity Code Description:
An award made to an institution solely for the support of a General Clinical Research Center where scientists conduct studies on a wide range of human diseases using the full spectrum of the biomedical sciences. Costs underwritten by these grants include those for renovation, for operational expenses such as staff salaries, equipment, and supplies, and for hospitalization. A General Clinical Research Center is a discrete unit of research beds separated from the general care wards. |
Clinical Trial: Tms For the Treatment of Severely Affected Stroke @ Beth Israel Deaconess Medical Center
Affect; Apoplexy; CRISP; Cerebral Stroke; Cerebrovascular Apoplexy; Cerebrovascular Stroke; Cerebrovascular accident; Clinical Trials; Clinical Trials, Phase II; Clinical Trials, Therapy; Clinical Trials, Unspecified; Computer Retrieval of Information on Scientific Projects Database; Controlled Clinical Trials; Crossing Over; Crossing Over, Genetic; Diffusion MRI; Diffusion Magnetic Resonance Imaging; Diffusion Weighted MRI; Double-Blind Method; Double-Blind Study; Double-Blinded; Double-Masked Method; Double-Masked Study; Funding; Genetic Crossing Over; Grant; Institution; Investigation; Investigators; Motor; NIH; National Institutes of Health; National Institutes of Health (U.S.); Patients; Phase 2 Clinical Trials; Phase II Clinical Trials; Placebo Control; QOL; Quality of life; Randomized; Research; Research Personnel; Research Resources; Researchers; Resources; Source; Stroke; Therapeutic Trials; Therapy Clinical Trials; United States National Institutes of Health; Vascular Accident, Brain; base; brain attack; cerebral vascular accident; clinical investigation; day; design; designing; diffusion tensor imaging; improved; motor deficit; nonsister chromatid exchange; novel; phase 2 study; phase 2 trial; phase II trial; protocol, phase II; randomisation; randomization; randomly assigned; response; stroke; stroke therapy; study, phase II
|
0.921 |
| 2009 — 2010 |
Fregni, Felipe |
R21Activity Code Description:
To encourage the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.) |
Investigation and Treatment of Central Nervous System Dysfunction in Chronic Pelv @ Beth Israel Deaconess Medical Center
DESCRIPTION (provided by applicant): The purpose of this protocol is to investigate the central nervous system dysfunction that is associated with chronic pelvic pain and also a possible novel treatment using a neuromodulatory tool - transcranial direct current stimulation (tDCS) - for this condition. This study is important as chronic pelvic pain can have a considerable impact in terms of interference with daily life activities and general well being which results in anxiety and depression. In addition, this condition has a relatively high prevalence - the prevalence rate of chronic pelvic pain in women in US is 3.7%, comparable with the numbers for other chronic conditions such as asthma (3.8%) and back pain (4.1%). Because chronic pelvic pain is often refractory to medical and surgical procedures and recent evidence suggests a central nervous system dysfunction - such as in the limbic areas (anterior cingulate cortex) - in chronic pelvic pain, we hypothesize that the pathophysiology of chronic pelvic pain is associated with abnormal activity in pain-related neural networks. This hypothesis is based on our pilot data showing that noninvasive brain stimulation (tDCS) induces a significant reduction in pain in these patients and also on our NIDDK-R03 funded study in which we showed that another technique of noninvasive brain stimulation reduces pain in chronic visceral pain due to pancreatitis and that changes in pain-related neural networks (as indexed by magnetic resonance spectroscopy) are found in these patients. Specifically, we will investigate the efficacy of tDCS in reducing pain in a cohort of chronic pelvic pain patients (with painful bladder syndrome or interstitial cystitis) via a phase-II, double-blinded, sham- controlled, parallel, randomized clinical trial and also assess the safety of this intervention via a battery of neurocognitive tests. Furthermore we will assess the impact of this treatment on the phenomenon of allodynia and hyperalgesia, which are known to be surrogates of central sensitization. Finally we will investigate the central neural dysfunction in these patients using the technique of magnetic resonance spectroscopy that can measure brain metabolites in a noninvasive and reliable manner. We hypothesize that our proposed intervention will reduce the pathological hyperactivity in the anterior cingulate gyrus in these patients. The results of this study may represent an important step for establishing a novel therapeutic approach for chronic pelvic pain and will also shed light on its pathophysiology. PUBLIC HEALTH RELEVANCE: Chronic pelvic pain results in a reduced quality of life, accounts for more than $2.8 billion dollars in direct annual healthcare expenses, and has indirect costs associated with absenteeism, reduced productivity, and hindered performance while at work. Patients who suffer from this painful, debilitating condition are often refractory to current pharmacological therapies. We therefore propose to investigate a novel therapeutic intervention using noninvasive brain stimulation and, in addition, investigate the neural basis of this disorder using magnetic resonance imaging - the results of this study will therefore provide insights into understanding the pathophysiology of chronic pelvic pain.
|
0.921 |